Health Sciences

UC San Diego Health Sciences schools, institutes and centers are at the forefront of discovery and transformation.

The Latest

UC San Diego and Deerfield Management Create Poseidon Innovation to Advance Disease-Curing Therapeutics

University of California San Diego and Deerfield Management announce today the creation of Poseidon Innovation, LLC to advance disease-curing therapeutics. Through Deerfield’s $65-million commitment in Poseidon, UC San Diego investigators will have the funding and support to weather risky early-stage processes and expedite the drug-development cycle, allowing patients to receive treatment faster.

New National Training Program Aims to Mainstream Glycosciences

Over the next five years, the National Heart, Lung, and Blood Institute, part of the National Institutes of Health, will award approximately $20 million to four academic centers to launch a new national Career Development Consortium for Excellence in Glycosciences.

Marijuana Found in Breast Milk up to Six Days after Use

To better understand how much marijuana or constituent compounds actually get into breast milk and how long it remains, researchers at University of California San Diego School of Medicine conducted a study, publishing online in Pediatrics.

Study Reveals How Enzyme Detects Ultraviolet Light Damage

In a paper published this week in the journal PNAS, researchers at University of California San Diego School of Medicine, with colleagues in Spain and Finland, describe for the first time how one type of RNA polymerase gets stalled by DNA lesions caused by exposure to ultraviolet (UV) light.

U.S. News & World Report Ranks UC San Diego Health Nationally

UC San Diego Health and its medical and surgical specialties have again been nationally ranked by U.S. News & World Report for 2018-19. Each year, U.S. News & World Report analyzes and reviews hospitals performance in a clinical specialties, procedures and conditions for its “Best Hospital” rankings. These rankings distinguish hospitals that provide excellent treatment for health conditions that require the most comprehensive care.

The Rising Price of Medicare Part D’s 10 Most Costly Medications

Researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego have found that the cost for the 10 “highest spend” medications in Medicare Part D — the U.S. federal government’s primary prescription drug benefit for older citizens — rose almost one-third between 2011 and 2015, even as the number of persons using these drugs dropped by the same amount.